hit a plateau on semaglutide I compare two weight loss medications with my patients every single week. Here's what the data actually shows. (Ozempic/Wegovy) delivered 13.7% average weight loss in clinical trials. That's significant. But Breaking Through the Semaglutide Plateau:

Patients may increase exercise intensity or duration as they lose weight and gain confidence, potentially leading to overuse injuries or delayed-onset muscle soreness that may be perceived as joint pain

Its a primary component in cellular health and mitochondrial management and instrumental in supporting your organs and their functions

Good care starts with discernment, not urgency. Considering Ozempic, Wegovy, Zepbound, or another GLP-1 medication

Through a reputable telehealth service like 10 Rx Home, you can consult with board-certified physicians who truly listen

This multifaceted approach not only supports weight loss but also addresses key factors in managing type 2 diabetes effectively